Engineering Escherichia coli for canthaxanthin and astaxanthin biosynthesis
1E. I. DuPont. de Nemours Inc., Wilmington, DE, USA. qiong.cheng@usa.dupont.com
Engineered Escherichia coli can produce carotenoids by assembling operons from various bacterial genes. Including the idi gene significantly boosts carotenoid yield, while ketolase and hydroxylase gene placement impacts astaxanthin purity.
Area of Science:
- Microbiology
- Metabolic Engineering
- Biotechnology
Background:
- Escherichia coli, a non-carotenogenic bacterium, can be engineered for carotenoid synthesis.
- Carotenoid production necessitates the heterologous expression of specific bacterial genes within E. coli.
- The isoprenoid pathway in E. coli can synthesize the farnesyl pyrophosphate precursor for carotenoids.
Purpose of the Study:
- To describe methods for assembling carotenoid biosynthesis operons in E. coli.
- To evaluate canthaxanthin and astaxanthin production using engineered operons.
- To investigate factors influencing carotenoid yield and purity in E. coli.
Main Methods:
- Assembling carotenoid synthesis operons from diverse bacterial gene clusters.
- Heterologous gene expression in Escherichia coli.
- Incorporating carotenoid modification genes (ketolases, hydroxylases) into operons.
Main Results:
- Operons containing the idi gene achieved over fivefold higher carotenoid titers compared to those lacking it.
- The purity of astaxanthin varied based on the bacterial source of ketolase and hydroxylase genes.
- Gene placement of ketolases and hydroxylases relative to the promoter influenced astaxanthin purity, with proximal expression yielding higher purity.
Conclusions:
- Engineering carotenoid biosynthesis operons in E. coli is feasible using genes from various bacterial sources.
- The idi gene is crucial for enhancing carotenoid titers in engineered E. coli.
- Optimizing the expression and arrangement of modification genes is critical for achieving high purity of specific carotenoids like astaxanthin.
More Related Videos
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
14:06Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays
Published on: November 12, 2012
Related Concept Videos
Production of Pharmaceuticals
Evolution of New Traits in Microbes
